Follow the NGL Fine-Chem Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, NGL Fine-Chem Limited has logged 16 insider filings. Market capitalisation: €20.1bn. The latest transaction was filed on 16 September 2023 (Sale). Among the most active insiders: SUNITA POTDAR. The full history is openly available.
16
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€955,425
16 ops.
Sell Volume
4Σ signal
Buys n/a€955,425 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,007 of 28,855 companies
50.9
score / 100
Value
31
Quality
70
FCF yld-2.3%
Earn yld2.4%
EV/EBITDA24.3x
ROE16%
Gross mgn52%
Net mgn9.6%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,358 shares@ ₹1,469.56195.8% of flowEquity SharesSEBI:8a0cf379c70058533a4eb51089d9c1675d546c1f
16 of 16 declarations
About NGL Fine-Chem Limited
NGL Fine-Chem Limited is a company specializing in the manufacture of fine chemicals and pharmaceutical products. It operates in the XBOM market and focuses on innovation and product quality.